# üíä Medication Analysis Report
**Generated:** 2025-12-28 08:44:01
**Analysis System:** MedicationAnalyzer (Comprehensive Drug Analysis)
**Analysis Cost:** $0.0384
**Duration:** 27.9s


---

## üìã Medication Overview
**Name:** Paracetamol
**Drug Class:** Non-opioid analgesic and antipyretic
**Analysis Confidence:** 0.95/1.00

---

## üß¨ Mechanism of Action
Paracetamol primarily exerts its effects centrally by inhibiting cyclooxygenase (COX-1 and COX-3) enzymes, reducing prostaglandin synthesis in the brain and spinal cord, which accounts for its analgesic and antipyretic properties. It has minimal peripheral anti-inflammatory activity due to negligibl...

---

## ‚öóÔ∏è Pharmacokinetics Summary
- **Absorption:** Paracetamol is rapidly and nearly completely absorbed from the small intestine following oral admini...
- **Metabolism:** Hepatic metabolism predominates via three main pathways: glucuronidation (50-60%), sulfation (25-35%...
- **Elimination:** Primarily renal excretion of inactive metabolites (glucuronide and sulfate conjugates account for >9...
- **Half-Life:** 1.5-3 hours in healthy adults; extended to 5-8 hours in hepatic impairment, up to 10 hours in neonates, and 3-4 hours in renal impairment.

---

## ‚ö†Ô∏è Key Safety Information

### ‚ö†Ô∏è BLACK BOX WARNINGS

1. Severe liver injury may occur with overdose (>4 g/day) or concomitant use with other paracetamol-containing products.
2. Risk of acute liver failure, transplantation, or death; early signs may be absent.
3. Do not exceed recommended dose; chronic use >3 g/day increases hepatotoxicity risk.

### Contraindications (3 identified)

- **Known hypersensitivity to paracetamol** (N/A)
- **Severe active hepatic impairment (Child-Pugh C)** (N/A)
- **G6PD deficiency** (N/A)

---

## üîó Interactions Summary

### üî¥ SEVERE Drug Interactions (1)

- **Chronic alcohol**
  - Effect: Enhanced hepatotoxicity risk....
  - Management: Avoid chronic alcohol; limit dose to 2 g/day....

### üü° Moderate Drug Interactions (3)

- **Warfarin**: Elevated INR and bleeding risk with doses >2 g/day....
- **Probenecid**: Prolonged half-life and increased toxicity risk....
- **Lamotrigine**: Decreased lamotrigine efficacy....

### Food Interactions (2)

- **Alcohol (acute/chronic)**: Separate by 4-6 hours if possible; counsel abstinence....
- **High-fat meal**: No adjustment needed....

---

## ‚úÖ Evidence-Based Recommendations

1. **N/A**
   - N/A...

2. **N/A**
   - N/A...

3. **N/A**
   - N/A...

4. **N/A**
   - N/A...


---

**For complete details including all interactions, dosing adjustments, and comprehensive recommendations, see the detailed report.**

‚ö†Ô∏è **DISCLAIMER:** This analysis is for educational and research purposes only. Always consult qualified healthcare providers for medication decisions.
